Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Hydromorphone 1.3mg capsules |
| BNF code | 040702050AAAEAE |
| Virtual Therapeutic Moiety | Hydromorphone |
| Date identifier became valid | 3 Jul 2023 |
| Previous product identifier | 322665006 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | capsule |
| Unit dose unit of measure | capsule |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Hydromorphone hydrochloride |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 1.300 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | capsule.oral |
| Dose Form | |
| Formulation | Oral capsule |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | Schedule 2 (CD) |
| Actual Medicinal Products | |
| Palladone 1.3mg capsules (Napp Pharmaceuticals Ltd) | |
| Virtual Medicinal Product Packs | |
| Hydromorphone 1.3mg capsules 56 capsule | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.